Impact of PharmaTE Trial on Glycemic Control, Diabetes Knowledge, Medication Adherence and Quality of Life in Type 2 Diabetes Patients: A Mixed-Method Study Protocol
Starting soon · Not applicable
Conditions studied: Type 2 Diabetes (T2DM), Glycemic Control, Diabetes Knowledge, Medication Adherence, Quality of Life
In brief
The goal of this clinical trial is to find out whether a pharmacist-led tele-educational program (PharmaTE trial) can help people with type 2 diabetes manage their condition better. The main questions this study aims to answer are: 1. Does the PharmaTE trial improve blood sugar control (HbA1c levels)? 2. Does it help patients better understand their condition? 3. Does it increase how well patients follow their medication schedule? 4. Does it improve the quality of life for patients with type 2 diabetes? 5. Is this type of tele-education program feasible and acceptable for patients? Participants will: Be randomly placed into one of two groups: Intervention group: Receive five virtual education sessions with a clinical pharmacist over the phone or via Zoom (each lasting 20-30 minutes), in addition to their usual diabetes care. Control group: Continue receiving standard diabetes care from their healthcare team without the additional pharmacist-led sessions. Complete assessments at the beginning and end of the study. These include: A blood test for HbA1c , Questionnaires on diabetes knowledge, medication adherence, and quality of life Some participants in the intervention group will be invited for interviews after the sessions to share their experiences and opinions about the program. Who can join? Adults aged 18-65 with uncontrolled type 2 diabetes (HbA1c \> 7%), receiving care at Ibrahim Bin Hamad Obaidullah Hospital in Ras Al-Khaimah, who speak Arabic and can provide consent.
Key facts
- Study ID
- NCT07043816
- Run by
- Rabia Hussain
- People needed
- 154
- Starts
- 2026-09-01
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2026-04-29
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients diagnosed with uncontrolled type 2 diabetes (defined as glycated haemoglobin [HbA1c] >7%) within the previous 12 months
- Adults (18 to 65 years) of either gender
- Prescribed at least one antidiabetic medication
- Have access to either a telephone or a mobile phone
- Treated in an outpatient facility in IBOH, RAK
- Arabic-speaking patients
- Patients who understand study information and are given written informed consent.
You may not qualify if…
- Under 18 years old
- Pregnant ladies
- Patients admitted to the emergency department
- Patients with severe hepatic or renal dysfunction
- Diagnosed with type 1 DM or diagnosed with gestational diabetes
- Having vision or hearing impairments and psychological problems
- Immunocompromised patients, e.g., organ transplants, AIDS, cancer patients, and patients on immunosuppressant therapy
- Patients with no or limited access to either a telephone or mobile phone, as well as those without reliable internet access
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.